Factor Xa Inhibitor

Related by string. Factor Xa inhibitor * factoring . factored . factors . Factors : X Factor Cher Lloyd . CERTAIN MARKET FACTORS SUCH . Risk Factors section . heading Risk Factors / xa . xAD . XAS . XA : Infor ERP XA . XA Spartan 3A . Scion xA . Infor XA / Inhibitors . inhibitors . inhibitor : proton pump inhibitors . proton pump inhibitors PPIs . small molecule inhibitor . proton pump inhibitor PPI * *

Related by context. All words. (Click for frequent words.) 71 Meets Primary Endpoint 70 Cholesterol Lowering Drug 69 Unfractionated Heparin 69 Phase III Clinical Trial 69 Fungal Infections 69 Drug Candidate 69 Phase 2a Clinical Trial 69 Mylan Receives Approval 69 Novel Antibiotic 69 Testosterone Gel 68 Epilepsy Drug 68 Generic Version 68 Patient Enrollment 68 Improves Survival 68 Phase IIb Trial 68 JAK Inhibitor 68 Gout Drug 67 Receives Orphan Drug Designation 67 Phase 2b Clinical Trial 67 Completes Patient Enrollment 67 Novel Oral 67 Phase 2a Trial 67 Rheumatoid Arthritis Patients 67 Severe Sepsis 67 Receives Approvable Letter 67 Earns Milestone Payment 67 Vaccine Candidate 67 RNAi Therapeutic 67 Pafuramidine 67 Teva Provides Update 67 Hsp# Inhibitor 67 First Patient Enrolled 67 Single Dose 67 Antitumor Activity 67 Patients Treated With 67 Prolongs Survival 67 Receives Positive Opinion 67 Disease Progression 67 Expanded Indication 67 Files IND 67 NDA Submission 67 Investigational Treatment 66 Submits NDA 66 Monotherapy 66 Carboplatin Paclitaxel 66 Osteoporosis Drug 66 Clinical Trial Results 66 FDA Accepts 66 Arthritis Drug 66 Rotavirus Vaccines 66 Phase III Trial 66 Presents Preclinical Data 66 Rotavirus Vaccine 66 Enlarged Prostate 66 Resistant Hypertension 66 Preclinical Data 66 Present Preclinical Data 66 Investigational Compound 66 Initiates Phase II 66 Oral Fingolimod 66 Rheumatoid Arthritis Drug 66 Patent Covering 66 Anemia Drug 66 First Patient Treated 66 Osteoporosis Drugs 66 Anti Tumor Activity 66 Pivotal Phase III 66 Vaccine Adjuvant 66 Phase 2b Trial 66 Recombinant Human 65 RNAi Therapeutics 65 Long Term Efficacy 65 Investigational Agent 65 Recurrent Breast Cancer 65 Lung Cancer Drug 65 Oral Formulation 65 Advanced Melanoma 65 Inhaled Insulin 65 First Patient Dosed 65 Cholesterol Drug 65 Combination Therapy 65 Tumor Growth 65 Tumor Targeting 65 Renal Cell Carcinoma 65 Invasive Fungal Infections 65 Initiates Enrollment 65 Thyroid Hormone 65 Demonstrates Sustained 65 Versus Placebo 65 Positive Opinion 65 Phase IIb Clinical Trial 65 Non Inferiority 65 Achieves Primary Endpoint 65 FDA Okays 65 Therapeutic Potential 65 Pooled Analysis 65 Phase 1b Clinical Trial 65 Completes Enrollment 65 Initiates Clinical Trial 65 MEK Inhibitor 65 Transdermal Patch 65 Demonstrates Significant 65 Demonstrated Significant 65 Brain Metastases 65 Therapeutic Antibody 65 Previously Treated 65 Regenerative Cells 65 IND Filing 65 Anti Tumor 65 Advanced Colorectal Cancer 65 Blood Pressure Drug 65 StaphVAX R 65 Lupus Drug 65 Antiviral Drugs 64 Fondaparinux 64 Postmenopausal Women 64 Anti Clotting Drug 64 Desvenlafaxine Succinate 64 Combination Treatment 64 Gentium Announces 64 Anti Inflammatory Drug 64 Metastatic Colorectal Cancer 64 Study Evaluating 64 FOLOTYN ® 64 Fast Track Status 64 Mg Uk 64 Treatment Naive Patients 64 Prostate Cancer Patients 64 Acne Drug 64 Glatiramer Acetate 64 Experimental Vaccine 64 Atopic Dermatitis 64 Generic Versions 64 Demonstrates Positive 64 HCV Protease Inhibitor 64 Adjuvant Treatment 64 Effectively Treats 64 Chronic Hepatitis B 64 Treatment Experienced 64 Testosterone Patch 64 Low Dose 64 Topical Treatment 64 Chronic Hepatitis C 64 Osteoporosis Treatment 64 Therapeutic Vaccine 64 Demonstrates Potent 64 Advanced Prostate Cancer 64 Appears Safe 64 Shows Promise Against 64 Shows Promising 64 Diabetic Neuropathic Pain 64 Drug Resistant 64 Patients Suffering 64 Combination REOLYSIN R 64 Oral Mucositis 64 Pulmonary Arterial Hypertension 64 Diamyd Medical Diamyd 64 Shows Efficacy 64 Universal Flu Vaccine 64 Complicated Skin 64 Node Positive 64 Drug Coated Stents 63 Hypercholesterolemia 63 Data Suggest 63 pralatrexate injection folate analogue 63 Monoclonal Antibody 63 Milestone Payment 63 Randomized Phase II 63 Treatment Naïve 63 Overactive Bladder 63 Randomized Double Blind 63 Initiates Clinical 63 Oral Calcitonin 63 Receives Milestone Payment 63 Psoriasis Drug 63 Ovarian Cancer Treatment 63 Statistically Significant 63 Schizophrenia Drug 63 Pivotal Phase 63 Oral Spray 63 Initiates Phase III 63 HCl Injection 63 Clinical Trial Evaluating 63 Treating Chronic 63 Diabetic Macular Edema 63 Survival Benefit 63 JAK2 Inhibitor 63 Statin Therapy 63 Seasonal Influenza Vaccine 63 Advanced Renal Cell 63 Dose Escalation 63 Receives Marketing Authorization 63 Dose Ranging 63 Well Tolerated 63 Demonstrates Potential 63 Wound Dressing 63 Bepreve TM 63 VIVITROL ® 63 Subgroup Analysis 63 Venous Thromboembolism 63 Prostate Cancer Vaccine 63 Cholesterol Lowering 63 Inhaled Nitric Oxide 63 Demonstrates Efficacy 63 Erectile Dysfunction Drug 63 Bone Metastases 63 Levels Linked 63 Improve Survival 63 TRANSDUR ™ 63 Benign Prostatic Hyperplasia 63 Treatment Shows Promise 63 Novel Mechanism 63 Previously Untreated 63 Immunomedics Announces 63 Presents Positive 63 Proves Effective 63 Investigational Drug 63 Avian Flu Vaccine 63 Oral Insulin 63 Improved Survival 63 Antibody Drug Conjugate 63 Sustained Reduction 63 Trodusquemine MSI 63 FDA Panel Recommends 63 Hormone Refractory Prostate Cancer 63 Protease Inhibitor 63 Pivotal Study 63 Phase 2b Study 63 Hormone Receptor Positive 63 Allergic Rhinitis 63 Ranolazine 63 Drug Shows Promise 63 GRAS Status 63 Small Molecule 63 Drug Combo 63 Interferon Beta 63 Presents Preclinical 63 Submits Biologics License Application 63 Pivotal Trial 62 Improves Outcomes 62 Cardiovascular Events 62 Epilepsy Drugs 62 Significantly Improved 62 Blood Clotting 62 Anticancer Activity 62 Elderly Patients 62 Artery Disease 62 Initiate Phase III 62 Clinical Efficacy 62 Humanized Anti 62 Hormone Therapy 62 Study Showed 62 Develop Novel 62 Granted Orphan Drug 62 Milestone Payments 62 AVI BioPharma Announces 62 Bone Marrow Cells 62 Colorectal Cancer Patients 62 Novel Compound 62 Is Well Tolerated 62 Embosphere R 62 Statin Drugs 62 Safinamide 62 Levaquin levofloxacin 62 Reduces Risk 62 Treatment Reduces 62 Androgen Deprivation Therapy 62 FDA Warns Against 62 Genetic Tests 62 Migraine Drug 62 Kidney Transplant Patients 62 Trial Evaluating 62 Cervical Dysplasia 62 Patients Treated 62 Peginterferon Alfa 2b 62 Medullary Thyroid Cancer 62 Relapsed Multiple Myeloma 62 Tumor Response 62 Post Operative 62 Proven Effective 62 Initiates Clinical Trials 62 TB Vaccine 62 Kidney Function 62 Vascular Grafts 62 Bazedoxifene 62 Bucindolol 62 Phase III Clinical Trials 62 Adjuvant Therapy 62 Systemic Delivery 62 HDAC Inhibitor 62 Hepatocellular Carcinoma 62 Blood Thinner 62 MOVIPREP R 62 Lowers Risk 62 Reports Preclinical Data 62 Hematological Cancers 62 Sangamo BioSciences Announces 62 Atypical Antipsychotic 62 Antitumor 62 Receives Complete Response 62 Nail Fungus 62 Vitrasert R 62 See CLINICAL PHARMACOLOGY 62 Nasal Sprays 62 Liver Toxicity 62 Itraconazole 62 Metabolic Disorder 62 Microplasmin 62 Unresectable 62 Brimonidine 62 Molecular Diagnostic Test 62 Randomized Clinical Trials 62 Synthetic Peptide 62 Spectrum Pharmaceuticals Announces 61 Receives Orphan Drug 61 Disease IBD 61 Randomized Trials 61 Patients Receiving 61 Acne Scars 61 Treatment Regimen 61 Initiate Clinical Trial 61 Antiplatelet Therapy 61 Long Term Outcomes 61 dependent kinase inhibitor 61 Therapeutic Efficacy 61 Advanced Ovarian Cancer 61 Beta Blocker 61 ACE Inhibitors 61 Novel Therapeutic 61 Excessive Sweating 61 Less Invasive 61 Study Reinforces 61 Inhalation Solution 61 Naive Patients 61 Mouse Model 61 Vascular Inflammation 61 FDA Approvals 61 Renal Cancer 61 Pharmacokinetic Study 61 Cervical Cancer Vaccine 61 ferumoxytol Injection 61 Phase III Trials 61 Endovascular Treatment 61 Weight Loss Supplement 61 Blood Pressure Drugs 61 Successfully Completes Phase 61 Cold Sores 61 Nuvelo Announces 61 Transdermal Delivery 61 Tesamorelin 61 Tezampanel 61 Lung Cancer Trial 61 Immunotherapeutic 61 Stem Cell Treatment 61 Randomized Controlled Trials 61 Vaginal Gel 61 Diet Pill 61 Antipsychotic Drug 61 Multicenter Randomized 61 Clinical Outcome 61 Bivalirudin 61 Pharmacyclics Announces 61 Initiate Phase II 61 Significantly Reduced 61 BioElectronics Announces 61 Intravenous Human 61 Pediatric Patients 61 Ebola Vaccine 61 Newly Diagnosed Multiple Myeloma 61 Pneumococcal Vaccine 61 R lenalidomide 61 Files Patent Application 61 Drug Fails 61 Diabetic Patients 61 Confirmatory Phase 61 Calcium Vitamin D 61 Treatment Resistant 61 Prospective Randomized 61 Metastatic Prostate Cancer 61 Diabetic Foot Ulcer 61 Nilotinib 61 Pivotal Clinical Trial 61 Augment TM 61 Moderate Drinking 61 Diabetic Nephropathy 61 Lung Cancer Survival 61 Cholesterol Drugs 61 Advanced Pancreatic Cancer 61 topically applied SEPA 61 Breast Cancer Recurrence 61 Weight Loss Drug 61 Hepatitis C Virus HCV 61 Initiates Dosing 61 Smallpox Vaccine 61 Elagolix 61 PRN FDA Approves 61 MKC# MKC# PP 61 Efficacy Trial 61 Vicriviroc 61 C1 Inhibitor 61 Benazepril 61 Asthma Treatment 61 FDA Approves Drug 61 Adjuvant Chemotherapy 61 Improve Outcomes 61 FDA Clears 60 Begins Dosing 60 Postmenopausal Osteoporosis 60 Receives SFDA Approval 60 Replacement Therapy 60 Study Casts Doubt 60 Receives FDA Clearance 60 Pre Cancerous 60 Renin Inhibitor 60 Stem Cell Transplants 60 Double Blind Placebo 60 Multiple Myeloma Patients 60 brand ciclesonide Nasal 60 Clinically Tested 60 Cancer Therapies 60 Equity Funds Declare 60 Immune Cells 60 Malaria Vaccine 60 Phase IIa Clinical Trial 60 Cardiovascular Outcomes 60 Adjunctive Therapy 60 Hepatic Encephalopathy 60 Patient Enrolment 60 Posaconazole 60 Vaccine Prevents 60 II Clinical Trial 60 Nicotine Vaccine 60 Premenopausal Women 60 Genetic Testing 60 Granulocyte Colony Stimulating Factor 60 Treating Heart Failure 60 Plaque Psoriasis 60 Genetically Engineered Animals 60 Announces Poster Presentations 60 Combo Therapy 60 Ovarian Cancer Risk 60 XOPENEX R 60 Cardiotoxicity 60 Files Investigational 60 Immunosuppressant 60 Biomarker Study 60 Relapsing Multiple Sclerosis 60 Weight Loss Pill 60 Anti Inflammatory 60 Protein Linked 60 Hypertensive Patients 60 Soft Tissue Sarcoma 60 Inflammatory Markers 60 Interferon Alpha 60 Laryngeal Cancer 60 Recombinant Protein 60 IND Application 60 Order Cheap Viagra 60 Bone Marrow Stem Cells 60 SUTENT ® 60 Therapeutic Antibodies 60 Glaucoma Treatment 60 Progenitor Cells 60 Predict Risk 60 Orphan Status 60 Asthma Attacks 60 Lowers Cholesterol 60 Abdominal Fat 60 Patients Undergoing 60 TO AVOID PREGNANCY WHILE 60 Tegretol carbamazepine 60 Anticancer Compound 60 Fortical R 60 Montelukast 60 Sapacitabine 60 Antipsychotic 60 FDA Approves 60 Randomized Double blind 60 Significantly Reduces 60 Bosutinib 60 Relieve Pain 60 Stronger Warnings 60 Visceral Fat 60 Tyrosine Kinase Inhibitor 60 Metastatic Melanoma 60 Symptom Relief 60 Efficacious 60 Antiviral Activity 60 Gastric Cancer 59 Embolization 59 Randomized Study 59 Study Demonstrates 59 Confirms Efficacy 59 Alternative Treatments 59 Mesothelioma Treatment 59 Phase III Pivotal 59 AnaSpec Introduces 59 Diabetic Neuropathy 59 Therapy Improves 59 Breast Cancer Cells 59 HER2 Positive Breast Cancer 59 Controlled Trial 59 Surgical Procedures 59 Submits Response 59 Lowering Blood Pressure 59 Significantly Improves 59 Relapsing Remitting Multiple Sclerosis 59 Chronic Constipation 59 BioElectronics Corporation Announces 59 Meta Analysis 59 Poniard Pharmaceuticals Announces 59 Shingles Vaccine 59 Contaminated Heparin 59 ALVESCO ® 59 Blood Glucose Meters 59 Substantially Reduce 59 Drug Eluting 59 Chronic Lymphocytic Leukemia 59 Peptide Vaccine 59 Brentuximab Vedotin SGN 59 Schizophrenia Treatment 59 Pramlintide 59 Breast Cancer Tumors 59 Study Shows Benefits 59 Milestone Payment From 59 Taro Receives 59 Weight Loss Diets 59 Receives CE Marking 59 Kinase Inhibitor 59 Minimally Invasive Treatment 59 Announces FDA Clearance 59 Patient Accrual 59 Initiates Phase 2b 59 Clinical Trial Data 59 Telaprevir VX 59 FDA Approval 59 Initiates Phase 59 Nymox NX 59 Influenza Vaccine 59 Immunosuppression 59 ARIXTRA R 59 Hematological Malignancies 59 Autologous Stem Cell Transplantation 59 Autoimmune Disease 59 Estrogen Therapy 59 Personalized Immunotherapy 59 Osteoarthritis Pain 59 Myeloma Patients 59 Combination Clinical Trial 59 Genes Linked 59 Virus Infection 59 Carotid Stenting 59 Sevelamer 59 Soy Isoflavones 59 Heart Transplant Recipients 59 Receives Fast Track 59 Antidepressants Linked 59 Nerve Regeneration 59 Randomized Phase 59 Prostate Tumors 59 Licenses Novel 59 Showed Significant 59 Uric Acid 59 Study Proves 59 Angiogenic 59 Novel Treatments 59 Infected Patients 59 Severe Asthma 59 Aphthasol R 59 Dupuytren Contracture 59 Biopharmaceutical Industry 59 Successfully Treated 59 Disease Modifying 59 Hepatitis B Vaccine 59 Hepatitis C Virus 59 Smooth Muscle 59 Topline Results 59 Slows Progression 59 Insulin Sensitivity 59 Commercialize Novel 59 Autoimmune Diseases 59 Sign Licensing Agreement 59 Demonstrates Ability 59 Obese Teens 59 SPX SPW PriceWatch Alert 59 Diagnostic Tools 59 Lung Cancer Patients 59 Virus Linked 59 Small Diameter 59 Chronic Sinusitis 59 Cancer Treatments 59 Pandemic Influenza Vaccine 59 Recurrent Glioblastoma 59 Phase IIa Trial 59 HER2 Positive 59 Generic Accutane 59 Numoisyn ® Lozenges 59 Acne Treatments 59 Prognostic Factors 58 Clinically Significant 58 Novel Peptide 58 Glucose Control 58 Randomized Clinical Trial 58 Tolerability 58 Suicidality 58 Mitral Valve Repair 58 Potent Antiviral Activity 58 Protein Involved 58 Adverse Effects 58 Drug Eluting Stent 58 Resubmission 58 Vitamin D Linked 58 Clinical Study 58 Melphalan 58 GeoMet Announces 58 Online Generic Cialis 58 Osteoarthritis Patients 58 Balloon Angioplasty 58 Inhaled Steroids 58 NICE Recommends 58 Antihemophilic Factor Recombinant Plasma 58 Immune Cell 58 Heart Failure Patients 58 VIVUS Qnexa 58 Growth Hormone Deficiency 58 Shows Promise 58 Stomach Cancer 58 Novel Therapies 58 Respiratory Virus 58 Immune Mediated 58 Antibody Discovery 58 Intravenous Formulation 58 Advanced Solid Tumors 58 Inhaled Liposomal Ciprofloxacin 58 DirectTV DTV PriceWatch Alert 58 Biotech Crops 58 Lower Blood Pressure 58 Anti CD# Antibody 58 Uterine Fibroid Embolization 58 Enrolls First 58 Tuberculosis Vaccine 58 Receives Patent 58 By Megan Ainscow 58 Neoadjuvant Chemotherapy 58 Prophylactic Treatment 58 Breast Cancer Treatment 58 Gene Mutation 58 Calcium Supplements 58 Oil Refineries Announces 58 Sustained Efficacy 58 Zicam Cold Remedy RapidMelts 58 Completes Patient Enrolment 58 Zicam Extreme 58 Platelet Inhibition 58 Hemodialysis Patients 58 Castration Resistant Prostate Cancer 58 Male Contraceptive 58 Acute Ischemic Stroke 58 Romidepsin 58 Gets FDA Clearance 58 Rabies Vaccine 58 Emerging Therapies 58 Topical Cream 58 Prostate Cancer Treatment 58 Human Antibody 58 Acute Heart Failure 58 Controlled Study 58 Analytical Tool 58 Aurora Kinase 58 Myelodysplastic Syndromes 58 Drug Eluting Stents 58 Clinical Trial Enrollment 58 Brain Cells 58 Anti Angiogenesis 58 Insulin Delivery 58 Colesevelam HCl 58 PROVENGE ® 58 Prostate Biopsy 58 Levocetirizine 58 Knee Osteoarthritis 58 Detainee Legislation 58 Formoterol 58 TM Drug Eluting 58 Embolic Protection 58 Patent Issued 58 Interferon Gamma 58 Organ Rejection 58 BENECOL R Spreads 58 Refractory Angina 58 Maven Semantic 58 Bipolar Depression 58 Treatment Naive 58 Nasal Spray 58 Mental Decline 58 Back Pain Sufferers 58 Companion Diagnostic 58 FDA Clearance 58 Antiplatelet 58 Eluting Stent 58 Anticancer Agent 58 robust interlibrary loan 58 STELARA TM 57 Chromium Picolinate 57 Radiofrequency Ablation 57 Sinus Care 57 Decongestant 57 oral disintegrating tablets 57 Onyx Pharmaceuticals Announces 57 Patient Outcomes 57 Anticancer Drug 57 Dose Finding 57 Late Breaker 57 HuMax Wnt 57 Impotence Drug 57 Online THE LOWEST 57 Circulating Tumor Cells 57 Liver Fibrosis 57 Sipuleucel T 57 Breast Tumor 57 #:#-# Abstract Free [006] 57 Unmet Medical 57 Spinal Fusion 57 Through Glycoscience 57 Pandemic Influenza Vaccines 57 Genes Predict 57 Ovarian Cancer Patients 57 Menopausal Symptoms 57 Neuroendocrine Tumors 57 ThermoDox R 57 Radical Prostatectomy 57 Randomized Phase III 57 Emissions Targets 57 BioSante Pharmaceuticals Announces 57 Attenuates 57 Protein Expression 57 Cognitive Deficits 57 Immunogenicity 57 Pivotal Trials 57 Blood Pressure Lowering 57 HPV Vaccine Gardasil 57 Non Invasive Treatment 57 Clinical Study Shows 57 Pathogen Detection 57 ST Elevation Myocardial 57 Medicure Announces 57 Transdermal System 57 Obese Patients 57 Commences Phase 57 Patients Enrolled 57 Accelerate Commercialization 57 Study Evaluates 57 Slow Progression 57 Initiate Phase 57 Epiduo 57 Protease Inhibitors 57 Oral Cladribine 57 Trastuzumab DM1 57 Innate Immune 57 #:#-# Abstract Free [009] 57 Dural Regeneration Matrix 57 Non Invasive 57 Cutaneous T 57 Pre Exposure Prophylaxis 57 Daclizumab 57 Treated Patients 57 Placebo Controlled Trial 57 Malignant Melanoma 57 Cancer Vaccines 57 Fastest Easiest 57 Japanese Encephalitis Vaccine 57 free DesotoExplorer.com registration 57 Preclinical Study 57 Insulin Resistance 57 Dry Powder Inhaler 57 Preclinical Efficacy 57 Submits IND 57 Partial Onset Seizures 57 Ofatumumab 57 Ozarelix 57 Commercialize 57 #:#-# Abstract Free [003] 57 Cypher Sirolimus 57 Lipid Lowering 57 VIVUS Announces 57 IIa Clinical Trial 57 Receptor Agonist 57 Total Knee Arthroplasty 57 Renal Tumors 57 Breast Cancer Patients 57 Phase III Pivotal Trial 57 Cell Transplant 57 Allergic Asthma 57 Collaborators Present 57 Tissue Engineered 57 Treat Anemia 57 Clinically Proven 57 Sitagliptin 57 MULLIGAN FAMILY FUN CENTER 57 Clinical Evaluation 57 Newly Diagnosed 57 #:#-# Abstract Free [008] 57 Exclusive License 57 Cholesterol Levels 57 Hand Sanitizers 57 Therapy Shows Promise 57 Chronic Heart Failure 57 Randomized Double Blind Placebo 57 Bone Graft 57 Acute Pain 57 Reusable Grocery Bags 57 BiTE Antibody 57 Relapsed Refractory 57 Glucose Monitoring 57 Cardiac Resynchronization 56 Cardiovascular Disease Risk 56 #:#-# Abstract Free [005] 56 Gene Therapy Trial 56 Elevated Levels 56 Fourth Quarter Cash Dividend 56 Symbol GRYE 56 Transfection Reagent 56 Breast Cancer Metastasis 56 Prevent Prostate Cancer 56 Oncolytic 56 Chronic Myeloid Leukemia 56 Multiple Ascending Dose 56 Guidelines Issued 56 Hepatitis C Treatment 56 Inflammatory Arthritis 56 Investigational Oral 56 Ischemic 56 radiation dermatitis Numoisyn ® 56 Enrolling Patients 56 Stent Thrombosis 56 Targeted Therapies 56 Kidney Transplants 56 Storage Made Simple 56 KRN# 56 ORENCIA ® 56 Fatty Foods 56 Lowers Blood Pressure 56 Epoetin Alfa 56 Genes Involved 56 Balance Sheet Restructuring 56 Stent Restenosis 56 Cyprus Reunification 56 Cancer Vaccine 56 Lowering Cholesterol 56 Stent Implantation 56 Long Lasting 56 Synta Announces 56 Reveals Positive 56 Amnesteem 56 sertraline Zoloft 56 Archexin 56 Migraine Relief 56 Weight Loss Supplements 56 Surgical Treatment 56 Obese Adults 56 Third Quarter Cash Dividend 56 Mycophenolate Mofetil 56 Left Atrial 56 Hepatitis C Genotype 56 Vascular Targeting Agents 56 Phase 2a Study 56 Novel Protein 56 pulmonology portfolio 56 Commence Phase 56 Radiofrequency Ablation RFA 56 DIRECT Trial 56 Weight Loss Pills 56 FDA Approves Expanded 56 Commences Phase III 56 Release Tablets 56 Oral Interferon 56 Inhibits 56 Baby Bibs 56 Diet Reduces 56 Vitamin Supplements 56 Cognitive Impairment 56 Astelin 56 Prescription Medications 56 PDUFA Date 56 Lung Cancer Risk 56 Medical Countermeasures 56 Solid Tumors 56 Basal Insulin 56 Clinical Trial Investigating REOLYSIN 56 Aneurysm Repair 56 Randomized Controlled Trial 56 Pivotal Phase II 56 Colorectal Cancer Risk 56 Enzyme Replacement Therapy 56 doi Abstract Free 56 Dialysis Patients 56 Acute Attacks 56 Preclinical Models 56 Emissions Cuts 56 Qutenza TM 56 Dose Escalation Study 56 Efficacy Results 56 Artificial Pancreas 56 Aggressive Breast Cancer 56 Monoclonal Antibodies 56 Bone Marrow Transplants 56 Dose Ranging Study 56 Ischemic Stroke 56 Chickenpox Vaccine 56 Skeletal Muscle 55 k Clearance 55 Hormonal Contraceptives 55 Advanced Gastric Cancer 55 Urinary Incontinence 55 Therapy Evaluation 55 Tesetaxel 55 HCl Tablets 55 C Reactive Protein 55 Antihistamine 55 Phase #b/#a clinical 55 Therapeutic Cloning 55 Soft Tabs 55 Corcept Therapeutics Announces 55 Begin Clinical Trials 55 Pharmacokinetics PK 55 Metastatic Renal Cell Carcinoma 55 Scientifically Proven 55 Vitamin D Levels 55 #:#-# Abstract Free [007] 55 Gaucher Disease 55 Mirror Neurons 55 Mammalian Cell Culture 55 Risk Stratification 55 Unstable Angina 55 Cell Transplants 55 Endothelial Cells 55 Study Validates 55 Nucleic Acids 55 Successfully Treats 55 Dosage Forms 55 Diet Linked 55 Inflammatory Diseases 55 Insulin Pen 55 Fast Track Designation 55 Saizen R 55 legendary SPACE INVADERS 55 #:#-# Abstract Free [002] 55 Submits Application 55 Collaborators Publish 55 Therapeutic Targets 55 Dose Response 55 Immune Function 55 Phase Ib Clinical Trial 55 Implantable Device 55 Electrophysiology Mapping 55 Amrubicin 55 #:#-# Abstract Free [004] 55 Key Milestones 55 Marketing Authorisation Application 55 Flavored Cigarettes 55 Ocrelizumab 55 Diagnostic Tests 55 Antiviral Therapy 55 PHASE III 55 albiglutide 55 ISTODAX ® 55 Wrinkle Treatment 55 Genetic Predisposition 55 Anticoagulant 55 Sirolimus Eluting Stent 55 Mln Share Buyback 55 Bird Flu Vaccine 55 Hospitalized Patients 55 Brain Function 55 Assay Kits 55 Novel Inhibitor 55 Randomized Evaluation 55 Lung Injury 55 Head Lice Treatment 55 Insulin Levels 55 Systems Concepts ASCI 55 Predict Dementia 55 Noriega Extradition 55 Zicam Cold Remedy Chewables 55 Adverse Outcomes 55 Active Rheumatoid Arthritis 55 #:#-# Abstract Free [001] 55 Eculizumab 55 Amino Acid 55 Adverse Event 55 Antacids 55 Mad Cow Testing 55 Orphan Drug Status 55 Herbal Supplements 55 Interferon Alfa 55 Clinical Outcomes 55 Obtains CE Mark 55 Drug Eluting Coronary Stent 55 Reperfusion Injury 55 synthetic siRNA

Back to home page